Spanish Society of Clinical, Family and Community Pharmacy (SEFAC), Madrid, Spain.
Giovanni Lorenzini Medical Foundation, Milan, Italy.
Inquiry. 2024 Jan-Dec;61:469580241274268. doi: 10.1177/00469580241274268.
Multidose drug dispensing (MDD) is the dispensing of different drugs in dose bags containing one, some, or all units of medicine that a patient needs to take at specific times. The aim of this narrative review is to provide an overview of the literature describing the use of MDD systems in community healthcare settings in patients with multimorbidity and polypharmacy. A literature search identified 14 studies examining adherence, medication knowledge, quality of drug prescription (including inappropriate drug use, drug-drug interactions), medication incidents, and drug changes after MDD initiation, as well as healthcare professional (HCP) and patient perspectives. There are limited data on MDD in community healthcare settings, particularly on outcomes such as adherence. Studies are mostly from Northern Europe. Patients selected for MDD are more likely to be older, female, cognitively impaired, and have a higher number of disease diagnoses and drugs than those who do not receive drugs through MDD. MDD is generally initiated for patients who have decreased capacity for medication management. Several advantages of MDD have been reported by patients and HCPs, and studies indicate that MDD can be improved by medication review, defining clear roles and responsibilities of HCPs in the medication management chain, and comprehensive follow-up of patients. Future development, implementation, and assessment of MDD systems in community healthcare should be designed in collaboration with HCPs and patients, to identify ways to optimize the systems and improve patient outcomes.
多剂量药物配给(MDD)是指将不同药物分装在剂量袋中,每个剂量袋中包含患者在特定时间内所需服用的一个、一些或全部单位的药物。本叙述性综述旨在提供社区医疗保健环境中多剂量药物配给系统在患有多种疾病和多种药物治疗的患者中应用的文献概述。文献检索确定了 14 项研究,这些研究检查了 MDD 启动后药物的顺应性、药物知识、药物处方质量(包括不适当的药物使用、药物相互作用)、药物事件和药物变化,以及医疗保健专业人员(HCP)和患者的观点。在社区医疗保健环境中,关于 MDD 的数据有限,特别是关于顺应性等结果的数据有限。这些研究主要来自北欧。与未接受 MDD 药物治疗的患者相比,选择接受 MDD 的患者更有可能年龄较大、女性、认知能力受损、有更多的疾病诊断和药物治疗。MDD 通常是为那些管理药物能力下降的患者启动的。患者和 HCP 报告了 MDD 的几个优点,研究表明,通过药物审查、确定 HCP 在药物管理链中的明确角色和责任以及对患者的全面随访,可以改进 MDD。未来 MDD 系统在社区医疗保健中的开发、实施和评估应与 HCP 和患者合作进行,以确定优化系统和改善患者结果的方法。